Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Corporate Profile for BML Pharmaceuticals Inc., dated March 24, 2000.


Business Editors

--(BUSINESS WIRE)

The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services.


Published Date:     March 24, 2000

Company Name:       BML Pharmaceuticals Inc.

Address:            1129 Northern Boulevard
                    Manhasset, NY 11030

Main Telephone
 Number:            516/869-5801

Chief Executive
 Officer:           Barry M. Libin

Chief Financial
 Officer:           Jack Goldhaber, CPA

Investor Relations
 Contact:           Robert Polke
 Business number:   516/869-5801
 IR E-mail:         bmlpharm@aol.com

Public Relations
 Contact:           Joanne Ramist
 Business number:   516/869-5801

Industry:           Pharmaceutical - Research & Development


Company Description: BML BML Broadcast Markup Language
BML Bodega Marine Laboratory (UC Davis)
BML Bean Markup Language
BML Business Management Layer
BML Better Markup Language (server-side HTML preprocessor)
BML Blue Man Library
 Pharmaceuticals Inc. is an integrated pharmaceutical company that researches, develops and manufactures a range of proprietary prescriptive and OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 pharmaceutical products in the areas of cancer treatment, infectious and inflammatory diseases. The Company's products are formulated into therapeutics that range from the prevention and treatment of periodontal disease Periodontal Disease Definition

Periodontal diseases are a group of diseases that affect the tissues that support and anchor the teeth. Left untreated, periodontal disease results in the destruction of the gums, alveolar bone (the part of the jaws where
, herpetic lesions and oral ulcers, to the severely debilitating de·bil·i·tat·ing
adj.
Causing a loss of strength or energy.


Debilitating
Weakening, or reducing the strength of.

Mentioned in: Stress Reduction
 oral mucositis which is the major dose limiting factor in radiation and chemotherapy treatment for cancer patients.

Utilizing the Company's proprietary technology, Trionic Enhanced Biologic Response Modifiers, the Company's products have exceptional effectiveness against a broad spectrum of microorganisms, as well as direct anti-inflammatory activity that block leukotriene leukotriene /leu·ko·tri·ene/ (-tri´en) any of a group of biologically active compounds derived from arachidonic acid that function as regulators of allergic and inflammatory reactions. , prostaglandin, and cytokine Cytokine

Any of a group of soluble proteins that are released by a cell to send messages which are delivered to the same cell (autocrine), an adjacent cell (paracrine), or a distant cell (endocrine).
 production.

The I-Dent International Division of the Company has developed, for global distribution, a full complement of oral care products for the prevention and treatment of periodontal disease and for cosmetic dentistry Cosmetic Dentistry Definition

Cosmetic dentistry includes a variety of dental treatments aimed at improving the appearance of the teeth.
Purpose
. These drugs are available as OTC non-prescriptive drugs to the professional and consumer markets.

BML also licenses or otherwise ventures its professional OTC products to companies with established sales, marketing, and distribution capabilities.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 24, 2000
Words:280
Previous Article:Trendwest Resorts Announces Its Expansion Into the Midwest.
Next Article:Corporate Profile for MR Valuation Consulting LLC, dated March 24, 2000.
Topics:



Related Articles
Mandela's mission.
Corporate Profile for McKesson Corp., dated Nov. 24, 1995.
Corporate Profile for Daiichi Pharmaceutical, dated May 31, 1996.
Corporate Profile for BioCryst Pharmaceuticals, Inc., dated Oct. 13, 2000.
10 HVR-HD240S "Data Rec-POT S". (Upfront).
Relating fresh concrete viscosity measurements from different rheometers.
In memoriam.
BML, Odashima Morioka Rinsyou to Collaborate in Clinical Laboratory Business.
OMRON Healthcare Announces Dissolution of Affiliated Company.
Toshiba, Zentek to Offer Integrated Solution for Terrestrial Digital Broadcasting Reception.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles